These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32968891)

  • 21. Statin use and site-specific risk of colorectal cancer in individuals with hypercholesterolemia from the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS).
    Lee JW; You NY; Kim Y; Kim Y; Kim J; Kang HT
    Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):701-709. PubMed ID: 31133496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
    Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
    Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study.
    Oh HJ; Lee HA; Moon CM; Ryu DR
    Yonsei Med J; 2020 Jun; 61(6):506-514. PubMed ID: 32469174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin use is associated with a lower risk of rotator cuff disease in patients with Type 2 diabetes mellitus.
    Chang R; Tu TY; Hung YM; Huang JY; Chou MC; Wei JC
    Diabetes Metab; 2022 Sep; 48(5):101368. PubMed ID: 35760373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin use is not associated with colorectal cancer incidence in type-2 diabetes patients: evidence from methods that avoid immortal time bias.
    Zhang HS; Yang Y; Lee S; Park S; Nam CM; Jee SH
    Int J Colorectal Dis; 2022 Aug; 37(8):1827-1834. PubMed ID: 35831458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metformin can reduce the risk of colorectal cancer].
    Fransgård T; Gögenur I
    Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    Lee MC; Chiang CY; Lee CH; Ho CM; Chang CH; Wang JY; Chen SM
    PLoS One; 2018; 13(10):e0205807. PubMed ID: 30335800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
    Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
    Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
    Oh TK; Song IA
    Acta Diabetol; 2021 Jun; 58(6):771-778. PubMed ID: 33582839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
    Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
    J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 39. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
    Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.